{"id":2048,"date":"2022-07-31T15:47:23","date_gmt":"2022-07-31T15:47:23","guid":{"rendered":"https:\/\/mgpindia.com\/fend\/?page_id=2048"},"modified":"2024-10-03T16:13:23","modified_gmt":"2024-10-03T16:13:23","slug":"drug-resistant","status":"publish","type":"page","link":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/","title":{"rendered":"Drug Resistant"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;Header&#8221; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F5F0EB&#8221; custom_padding=&#8221;0px|0px|0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;100px||||false|false&#8221; custom_padding_tablet=&#8221;30px||||false|false&#8221; custom_padding_phone=&#8221;20px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;Roboto|500|||||||&#8221; header_text_color=&#8221;#000000&#8243; header_font_size=&#8221;70px&#8221; header_line_height=&#8221;1.15em&#8221; header_font_size_tablet=&#8221;40px&#8221; header_font_size_phone=&#8221;24px&#8221; header_font_size_last_edited=&#8221;on|desktop&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h1>Drug Resistant Protocol<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/lab-test-14-cropped.jpg&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;|-10vw|||false|false&#8221; custom_margin_tablet=&#8221;|0%|||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_image=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/02\/high-school_34.png&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat-x&#8221; z_index=&#8221;500&#8243; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;0px||||false|false&#8221; custom_margin_last_edited=&#8221;off|desktop&#8221; custom_padding=&#8221;40px|40px|40px|40px|true|true&#8221; custom_padding_tablet=&#8221;30px|30px|30px|30px|true|true&#8221; custom_padding_phone=&#8221;20px|20px|20px|20px|true|true&#8221; box_shadow_style=&#8221;preset3&#8243; box_shadow_vertical=&#8221;60px&#8221; box_shadow_blur=&#8221;60px&#8221; box_shadow_spread=&#8221;0px&#8221; box_shadow_color=&#8221;rgba(14,15,43,0.1)&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;40px||40px||true|false&#8221; custom_padding_tablet=&#8221;40px||40px||true|false&#8221; custom_padding_phone=&#8221;40px||40px||true|false&#8221; custom_padding_last_edited=&#8221;on|desktop&#8221; header_font_size_tablet=&#8221;55px&#8221; header_font_size_last_edited=&#8221;off|desktop&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Drug-resistant tuberculosis, particularly multi-drug resistant\/rifampin-resistant TB (MDR\/RR-TB) remains a public health threat making up 3.3% of new TB cases and 17.7% of previously treated cases. The World Health Organization (WHO) has highlighted the development of expanded, rapid molecular drug susceptibility tests as a key priority to tackle drug-resistant TB (DR-TB) and to replace biohazardous, lengthy, and often inaccessible culture-based drug susceptibility testing (DST) methods. Recent and anticipated changes in TB treatment approaches for drug-sensitive and drug-resistant TB, aimed to reduce length of therapy, pill burden, and toxicity, as well as growing knowledge around molecular mechanisms of resistance, have set the stage and highlighted the need for new rapid drug susceptibility technologies.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_id=&#8221;drug-resistant&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,3_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.17.6&#8243; text_text_color=&#8221;#ffffff&#8221; text_line_height=&#8221;1.8em&#8221; header_text_color=&#8221;#000000&#8243; header_2_font=&#8221;Roboto||||||||&#8221; header_2_text_align=&#8221;center&#8221; header_2_text_color=&#8221;#000000&#8243; header_2_font_size=&#8221;40px&#8221; header_2_line_height=&#8221;1.7em&#8221; background_color=&#8221;#2E548A&#8221; max_width=&#8221;600px&#8221; custom_margin=&#8221;||||false|false&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;||||false|false&#8221; custom_margin_last_edited=&#8221;on|desktop&#8221; custom_padding=&#8221;60px|60px|60px|60px|true|true&#8221; header_2_font_size_tablet=&#8221;48px&#8221; header_2_font_size_phone=&#8221;30px&#8221; header_2_font_size_last_edited=&#8221;on|phone&#8221; border_radii=&#8221;on|50px|50px|50px|50px&#8221; border_color_all=&#8221;#BE7B61&#8243; box_shadow_style=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?resize=881%2C881&#038;ssl=1\" width=\"881\" height=\"881\" alt=\"\" class=\"wp-image-2081 alignnone size-full\" srcset=\"https:\/\/i0.wp.com\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?w=881&amp;ssl=1 881w, https:\/\/i0.wp.com\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?resize=300%2C300&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?resize=150%2C150&amp;ssl=1 150w, https:\/\/i0.wp.com\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?resize=768%2C768&amp;ssl=1 768w, https:\/\/i0.wp.com\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png?resize=480%2C480&amp;ssl=1 480w\" sizes=\"(max-width: 881px) 100vw, 881px\" \/><\/p>\n<p style=\"text-align: center;\">[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;3_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_font_size_tablet=&#8221;55px&#8221; header_font_size_last_edited=&#8221;off|desktop&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Of highest priority are rapid tests of low to moderate complexity that detect resistance to isoniazid, rifampin, and fluoroquinolones, as well as low to high complexity rapid tests that can detect resistance to drugs conferred by alterations in more expansive bacterial gene regions (e.g. pyrazinamide). Advances in biology and technology have facilitated the development of novel in vitro assays. However, rigorous evaluations using specimens from individuals in intended settings of use are needed to identify and prioritize the best-performing tests and inform their iterative development.<\/p>\n<p>The FEND DR-TB program enrolls adults with rifampin-resistant tuberculosis, noninvasively obtains relevant clinical specimens, and meticulously tests those specimens using conventional WHO-endorsed tuberculosis diagnostics and investigational tuberculosis diagnostic assays to classify each participant with regard to tuberculosis drug susceptibility status.\u00a0<\/p>\n<p>The FEND DR-TB program enrolls participants from 2 in-country sites in Moldova and Vietnam.<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_team_member name=&#8221;Yingda Xie&#8221; position=&#8221;MD&#8221; image_url=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/06\/Yingda-Xie.jpg&#8221; facebook_url=&#8221;mailto:ylx1@njms.rutgers.edu&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; header_font_size=&#8221;16px&#8221; body_font_size=&#8221;13px&#8221; body_line_height=&#8221;1.5em&#8221; link_option_url=&#8221;https:\/\/fend-tb.org\/yingda-xie\/&#8221; box_shadow_style_image=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_team_member][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_team_member name=&#8221;Adam Penn-Nicholson&#8221; position=&#8221;PhD&#8221; image_url=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/06\/Adam-Penn-Nicholson.jpg&#8221; facebook_url=&#8221;mailto:adam.penn-nicholson@finddx.org&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; header_font_size=&#8221;16px&#8221; body_font_size=&#8221;13px&#8221; body_line_height=&#8221;1.5em&#8221; link_option_url=&#8221;https:\/\/fend-tb.org\/adam-penn-nicholson\/&#8221; box_shadow_style_image=&#8221;preset3&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_team_member][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F5F0EB&#8221; custom_padding=&#8221;0px||0px||true|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; use_custom_gutter=&#8221;on&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; background_image=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/high-school_22.png&#8221; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat-x&#8221; custom_padding=&#8221;80px|80px|80px|80px|true|true&#8221; custom_padding_tablet=&#8221;80px|80px|80px|80px|true|true&#8221; custom_padding_phone=&#8221;80px|80px|80px|80px|true|true&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2022\/08\/moldova-map.jpg&#8221; url=&#8221;https:\/\/fend-tb.org\/sites\/moldova\/&#8221; use_overlay=&#8221;on&#8221; overlay_icon_color=&#8221;#FFFFFF&#8221; hover_overlay_color=&#8221;rgba(0,0,0,0.5)&#8221; hover_icon=&#8221;&#x4c;||divi||400&#8243; align=&#8221;center&#8221; module_class=&#8221;pa-image-hover-moldova&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||true|true&#8221; global_colors_info=&#8221;{}&#8221; src__hover_enabled=&#8221;off|desktop&#8221; filter_saturate__hover_enabled=&#8221;on|hover&#8221; filter_saturate__hover=&#8221;100%&#8221; filter_brightness__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover=&#8221;100%&#8221; src__hover=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/02\/university-of-oxford-logo.png&#8221;][\/et_pb_image][et_pb_button button_url=&#8221;https:\/\/fend-tb.org\/sites\/moldova\/&#8221; button_text=&#8221;Moldova&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#b3b3b3&#8243; button_bg_color=&#8221;RGBA(255,255,255,0)&#8221; button_border_width=&#8221;0px&#8221; button_letter_spacing=&#8221;2px&#8221; button_font=&#8221;Roboto|||on|||||&#8221; button_icon=&#8221;&#x39;||divi||400&#8243; button_on_hover=&#8221;off&#8221; custom_padding=&#8221;|||0px|false|false&#8221; global_colors_info=&#8221;{}&#8221; button_text_color__hover_enabled=&#8221;on|hover&#8221; button_text_color__hover=&#8221;#CB5341&#8243; button_bg_color__hover_enabled=&#8221;on|hover&#8221; button_bg_color__hover=&#8221;RGBA(255,255,255,0)&#8221;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;14px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>IPP Chisinau<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/06\/vietnam-map-2.jpg&#8221; title_text=&#8221;Vietnam&#8221; url=&#8221;https:\/\/fend-tb.org\/sites\/vietnam\/&#8221; use_overlay=&#8221;on&#8221; overlay_icon_color=&#8221;#FFFFFF&#8221; hover_overlay_color=&#8221;rgba(0,0,0,0.5)&#8221; hover_icon=&#8221;&#x4c;||divi||400&#8243; align=&#8221;center&#8221; src_last_edited=&#8221;off|desktop&#8221; module_class=&#8221;pa-image-hover-vietnam&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; global_colors_info=&#8221;{}&#8221; src__hover_enabled=&#8221;off|desktop&#8221; filter_saturate__hover_enabled=&#8221;on|hover&#8221; filter_saturate__hover=&#8221;100%&#8221; filter_brightness__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover=&#8221;100%&#8221; src__hover=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/02\/frontier-science-foundation-logo.png&#8221;][\/et_pb_image][et_pb_button button_url=&#8221;https:\/\/fend-tb.org\/sites\/vietnam\/&#8221; button_text=&#8221;Vietnam&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#b3b3b3&#8243; button_bg_color=&#8221;RGBA(255,255,255,0)&#8221; button_border_width=&#8221;0px&#8221; button_letter_spacing=&#8221;2px&#8221; button_font=&#8221;Roboto|||on|||||&#8221; button_icon=&#8221;&#x39;||divi||400&#8243; button_on_hover=&#8221;off&#8221; custom_padding=&#8221;|||0px|false|false&#8221; global_colors_info=&#8221;{}&#8221; button_text_color__hover_enabled=&#8221;on|hover&#8221; button_text_color__hover=&#8221;#CB5341&#8243; button_bg_color__hover_enabled=&#8221;on|hover&#8221; button_bg_color__hover=&#8221;RGBA(255,255,255,0)&#8221;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;14px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>\u00a0NLH<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/06\/sa.jpg&#8221; title_text=&#8221;South Africa&#8221; url=&#8221;https:\/\/fend-tb.org\/sites\/south-africa\/&#8221; use_overlay=&#8221;on&#8221; overlay_icon_color=&#8221;#FFFFFF&#8221; hover_overlay_color=&#8221;rgba(0,0,0,0.5)&#8221; hover_icon=&#8221;&#x4c;||divi||400&#8243; align=&#8221;center&#8221; module_class=&#8221;pa-image-hover-sa&#8221; _builder_version=&#8221;4.17.6&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; src__hover_enabled=&#8221;off|desktop&#8221; filter_saturate__hover_enabled=&#8221;on|hover&#8221; filter_saturate__hover=&#8221;100%&#8221; filter_brightness__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover_enabled=&#8221;on|hover&#8221; filter_opacity__hover=&#8221;100%&#8221; src__hover=&#8221;https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/02\/find-logo.png&#8221;][\/et_pb_image][et_pb_button button_url=&#8221;https:\/\/www.fend-tb.org\/staging\/9960\/sites\/south-africa\/&#8221; button_text=&#8221;South Africa&#8221; _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; custom_button=&#8221;on&#8221; button_text_size=&#8221;16px&#8221; button_text_color=&#8221;#b3b3b3&#8243; button_bg_color=&#8221;RGBA(255,255,255,0)&#8221; button_border_width=&#8221;0px&#8221; button_letter_spacing=&#8221;2px&#8221; button_font=&#8221;Roboto|||on|||||&#8221; button_icon=&#8221;&#x39;||divi||400&#8243; button_on_hover=&#8221;off&#8221; custom_padding=&#8221;|||0px|false|false&#8221; global_colors_info=&#8221;{}&#8221; button_text_color__hover_enabled=&#8221;on|hover&#8221; button_text_color__hover=&#8221;#CB5341&#8243; button_bg_color__hover_enabled=&#8221;on|hover&#8221; button_bg_color__hover=&#8221;RGBA(255,255,255,0)&#8221;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.24.3&#8243; _module_preset=&#8221;default&#8221; text_font_size=&#8221;14px&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>Nolungile<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; background_enable_color=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#FFFFFF&#8221; custom_padding=&#8221;|40px|80px|40px|false|true&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; module_id=&#8221;graphs&#8221; sticky_enabled=&#8221;0&#8243;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;003e9429-8e11-4d9e-968b-8881092bbf81&#8243; header_2_font=&#8221;Roboto|500|||||||&#8221; header_2_text_align=&#8221;center&#8221; header_2_text_color=&#8221;#000000&#8243; text_orientation=&#8221;center&#8221; custom_margin=&#8221;||0px||false|false&#8221; custom_padding=&#8221;||30px||false|false&#8221; header_2_font_size_tablet=&#8221;30px&#8221; header_2_font_size_phone=&#8221;20px&#8221; header_2_font_size_last_edited=&#8221;on|desktop&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2>FEND-TB Drug Resistance Protocol Enrollment By Country<\/h2>\n<p>N = 512<\/p>\n<p>[\/et_pb_text][et_pb_image src=&#8221;https:\/\/www.fend-tb.org\/staging\/9960\/wp-content\/uploads\/2024\/10\/dr-protocol-graph.png&#8221; title_text=&#8221;dr protocol graph&#8221; _builder_version=&#8221;4.27.2&#8243; _module_preset=&#8221;default&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;60%&#8221; width_phone=&#8221;&#8221; width_last_edited=&#8221;on|phone&#8221; module_alignment=&#8221;center&#8221; animation_style=&#8221;slide&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Drug Resistant ProtocolDrug-resistant tuberculosis, particularly multi-drug resistant\/rifampin-resistant TB (MDR\/RR-TB) remains a public health threat making up 3.3% of new TB cases and 17.7% of previously treated cases. The World Health Organization (WHO) has highlighted the development of expanded, rapid molecular drug susceptibility tests as a key priority to tackle drug-resistant TB (DR-TB) and to replace [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1412,"menu_order":3,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"nf_dc_page":"","_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"folder":[],"class_list":["post-2048","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Drug Resistant - FEND-TB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Drug Resistant - FEND-TB\" \/>\n<meta property=\"og:description\" content=\"Drug Resistant ProtocolDrug-resistant tuberculosis, particularly multi-drug resistant\/rifampin-resistant TB (MDR\/RR-TB) remains a public health threat making up 3.3% of new TB cases and 17.7% of previously treated cases. The World Health Organization (WHO) has highlighted the development of expanded, rapid molecular drug susceptibility tests as a key priority to tackle drug-resistant TB (DR-TB) and to replace [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/\" \/>\n<meta property=\"og:site_name\" content=\"FEND-TB\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-03T16:13:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/\",\"url\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/\",\"name\":\"Drug Resistant - FEND-TB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fend-tb.org\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/drug-resistant-bacteria.png\",\"datePublished\":\"2022-07-31T15:47:23+00:00\",\"dateModified\":\"2024-10-03T16:13:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fend-tb.org\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/drug-resistant-bacteria.png\",\"contentUrl\":\"https:\\\/\\\/fend-tb.org\\\/wp-content\\\/uploads\\\/2022\\\/07\\\/drug-resistant-bacteria.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/protocols\\\/drug-resistant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.fend-tb.org\\\/staging\\\/9960\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Protocols\",\"item\":\"https:\\\/\\\/www.fend-tb.org\\\/protocols\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Drug Resistant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.fend-tb.org\\\/#website\",\"url\":\"https:\\\/\\\/www.fend-tb.org\\\/\",\"name\":\"FEND-TB\",\"description\":\"Feasibility of Novel Diagnostics for TB in Endemic Countries\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.fend-tb.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Drug Resistant - FEND-TB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/","og_locale":"en_US","og_type":"article","og_title":"Drug Resistant - FEND-TB","og_description":"Drug Resistant ProtocolDrug-resistant tuberculosis, particularly multi-drug resistant\/rifampin-resistant TB (MDR\/RR-TB) remains a public health threat making up 3.3% of new TB cases and 17.7% of previously treated cases. The World Health Organization (WHO) has highlighted the development of expanded, rapid molecular drug susceptibility tests as a key priority to tackle drug-resistant TB (DR-TB) and to replace [&hellip;]","og_url":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/","og_site_name":"FEND-TB","article_modified_time":"2024-10-03T16:13:23+00:00","og_image":[{"url":"https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/","url":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/","name":"Drug Resistant - FEND-TB","isPartOf":{"@id":"https:\/\/www.fend-tb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/#primaryimage"},"image":{"@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/#primaryimage"},"thumbnailUrl":"https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png","datePublished":"2022-07-31T15:47:23+00:00","dateModified":"2024-10-03T16:13:23+00:00","breadcrumb":{"@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/#primaryimage","url":"https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png","contentUrl":"https:\/\/fend-tb.org\/wp-content\/uploads\/2022\/07\/drug-resistant-bacteria.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fend-tb.org\/staging\/9960\/protocols\/drug-resistant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fend-tb.org\/staging\/9960\/"},{"@type":"ListItem","position":2,"name":"Protocols","item":"https:\/\/www.fend-tb.org\/protocols\/"},{"@type":"ListItem","position":3,"name":"Drug Resistant"}]},{"@type":"WebSite","@id":"https:\/\/www.fend-tb.org\/#website","url":"https:\/\/www.fend-tb.org\/","name":"FEND-TB","description":"Feasibility of Novel Diagnostics for TB in Endemic Countries","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fend-tb.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/pages\/2048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/comments?post=2048"}],"version-history":[{"count":6,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/pages\/2048\/revisions"}],"predecessor-version":[{"id":3207,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/pages\/2048\/revisions\/3207"}],"up":[{"embeddable":true,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/pages\/1412"}],"wp:attachment":[{"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/media?parent=2048"}],"wp:term":[{"taxonomy":"folder","embeddable":true,"href":"https:\/\/www.fend-tb.org\/staging\/9960\/wp-json\/wp\/v2\/folder?post=2048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}